Monoclonal Antibody Treatments for Migraines
he next few years hold promise for “exciting” developments in treating migraines, according to Peter J. Goadsby, MD, of the University of California San Francisco.
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
he next few years hold promise for “exciting” developments in treating migraines, according to Peter J. Goadsby, MD, of the University of California San Francisco.